Dianthus Therapeutics, Inc.
News
Dianthus Therapeutics to Participate in Three Healthcare Investor Conferences in September
Globe Newswire NEW YORK and WALTHAM, Mass., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to advancing the next generation of...\n more…
Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Sees Significant Increase in Short Interest
Ticker Report Dianthus Therapeutics, Inc. (NASDAQ:DNTH - Get Free Report) was the recipient of a significant increase in short interest in the month of August. As of August 15th, there was short interest totalling...\n more…
Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Receives $44.71 Average Price Target from Analysts
Ticker Report Shares of Dianthus Therapeutics, Inc. (NASDAQ:DNTH - Get Free Report) have received a consensus recommendation of "Buy" from the ten research firms that are currently covering the company, MarketBeat...\n more…
SG Americas Securities LLC Buys Shares of 4,333 Dianthus Therapeutics, Inc. (NASDAQ:DNTH)
Ticker Report SG Americas Securities LLC purchased a new stake in shares of Dianthus Therapeutics, Inc. (NASDAQ:DNTH - Free Report) in the second quarter, according to its most recent 13F filing with the...\n more…
Critical Comparison: Dianthus Therapeutics (NASDAQ:DNTH) and Apollomics (NASDAQ:APLM)
Ticker Report Dianthus Therapeutics (NASDAQ:DNTH - Get Free Report) and Apollomics (NASDAQ:APLM - Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two...\n more…